XML 25 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Operating expenses:    
Research and development $ 3,054,025 $ 776,256
General and administrative 3,586,196 829,366
Total operating expenses 6,640,221 1,605,622
Operating loss (6,640,221) (1,605,622)
Other income (expense):    
Change in fair value of derivative liability (26,500) (79,500)
Interest income (expense), net 47,225 (40,933)
Grant income 1,157,449 735,075
Total other income (expense) 1,178,174 614,642
Loss before income taxes (5,462,047) (990,980)
Net loss $ (5,462,047) $ (990,980)
Basic and diluted loss per common share $ (0.87) $ (3.51)
Weighted average number of common shares outstanding, basic and diluted 6,308,961 282,614